Nkarta, Inc.

NASDAQ:NKTX

Biotechnology

Healthcare
$1.12 +3.41%

+$0.09 today

Market cap
$80.22M
Beta
0.90
P/E (TTM)
-2.0
EPS (TTM)
-$1.35
52W Low $1.63High $3.65

Volume 0.66M

Average 0.75M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$88.70M

FY 2025 · Annual

Investing Cash Flow

$100.32M

FY 2025 · Annual

Financing Cash Flow

$141,000.00

FY 2025 · Annual

-99.9% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(86.08M)(113.84M)(117.5M)(108.79M)(104.08M)
Depreciation & Amortization1.76M2.64M5.87M2.24M4.61M
Deferred Income Tax3.24M0000
Stock-Based Compensation14.46M16.86M17.2M16.73M8.56M
Change in Working Capital(1.64M)33.74M10.93M(12.16M)(435K)
Accounts Receivables00000
Inventory00000
Accounts Payables2.79M2.76M4.22M(4.47M)2.46M
Other Working Capital(4.44M)30.98M6.7M(7.69M)(2.9M)
Other Non-Cash Items337K3.61M(2.65M)2.29M2.65M
Operating Cash Flow(67.93M)(57M)(86.16M)(99.7M)(88.7M)
Capital Expenditures(5.03M)(47.11M)(28.15M)(4.41M)(1.21M)
Acquisitions (Net)(37.56K)137.58K000
Purchases of Investments(227.28M)(385.89M)(260.23M)(406.38M)(238.57M)
Sales of Investments264.84M248.31M367.4M281.23M340.09M
Other Investing Activities37.56K(137.58K)000
Investing Cash Flow32.53M(184.69M)79.02M(129.56M)100.32M
Debt Repayment00000
Common Stock Issued1.2M217.17M691K225.07M141K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities01.84M01.01M0
Financing Cash Flow1.2M219.01M691K226.08M141K
Effect of Forex Changes00000
Net Change in Cash(34.19M)(22.68M)(6.45M)(3.17M)11.76M
Free Cash Flow(72.95M)(104.11M)(114.31M)(104.11M)(89.91M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$104.1M
+ D&A$4.6M
+ Stock-Based Comp$8.6M
+ Deferred Tax$0
- Working Capital-$435.0K
+ Other Non-Cash$2.6M
= Operating Cash Flow-$88.7M
- Capex-$1.2M
= Free Cash Flow-$89.9M

Analysis

FY2025 free cash flow is -$89.9M. FCF conversion is 86.4% of net income. Operating cash flow was -$88.7M, with capex of -$1.2M. The largest bridge item is Stock-Based Comp at $8.6M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 9, 2026
8-KCurrent reportNov 6, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
8-KCurrent reportAug 10, 2026

Does NKTX generate free cash flow?

Nkarta, Inc. (NKTX) generated -$89.91M of free cash flow in fiscal 2025.

How much operating cash flow does NKTX produce?

Operating cash flow was -$88.70M, before capital expenditures of $1.21M.